RSS

antibodies

A North East recombinant antibody manufacturer has developed custom protein purification systems to help increase its production throughput. Read more

News

ProBioGen (service and technology provider for complex therapeutic glycoproteins) and Pionyr Immunotherapeutics have initiated a second immune-oncology contract development and manufacturing project. Read more

News

Catalent Pharma Solutions, global provider of advanced delivery technologies and development solutions, has announced it will adopt Berkeley Lights’ Beacon optofluidic platform to accelerate its cell line development workflow Read more

Technology

IONTAS, a company focused on the discovery and optimisation of fully human antibodies, has signed a collaboration agreement with Korean-based LG Chem to identify therapeutic oncology leads. Read more

News

Biotechnology company focused on the discovery and optimisation of fully human antibodies, IONTAS, has been awarded a major grant to support ongoing research into its novel antibody platform, KnotBody. Read more

News

Company focused on the discovery and optimisation of fully human antibodies, IONTAS, and a private biopharmaceutical company, aTen Therapeutics, have announced a collaboration for the discovery of therapeutic oncology leads. Read more

News

A collaboration between IONTAS, a company focused on the discovery and optimisation of fully human antibodies, and IGEM Therapeutics, an immunologist-oncology company, for the identification of novel IgE antibodies for cancer targets. Read more

News

German service and technology provider, ProBioGen, and immune-oncology company, Surface Oncology, have signed a second antibody development project for the development and manufacture of another antibody for potential use in clinical trials. Read more

News

Biotechnology company, ADC Biotechnology, has announced that it is developing a new ‘downstream bioconjugation’ method that will enable conjugation and antibody purification to be performed concurrently. Read more

News

Two recently published clinical studies have demonstrated a new approach using antibodies to target specific chemicals in the brain may help significantly reduce the incidence and severity of migraines. Read more

News

Regeneron Pharmaceuticals has announced plans to discontinue further clinical development of its antibody, suptavumab, for respiratory syncytial virus, as it has not met the primary endpoint of preventing infections in infants in the Phase III study Read more

News

BBI Solutions have launched more than 20 new antibodies in their product portfolio as a result of demands in the market place. This extended portfolio now includes cardiac, cancer, inflammation and fertility markers. Read more

News

Cambridge Research Biochemicals (CRB), specialist in the synthesis of custom peptides and antibody production has announced the release of its new Discovery Antibodies catalogue. Read more

News

Alastair Smith, Avacta Life Sciences, outlines the company’s work developing engineered alternatives to antibodies Read more

Opinion

Kymab, a Cambridge-based antibodies-to-medicines company, is featured in the top ten of The Sunday Times Tech Track ‘Ones to Watch’ 2015 list Read more

News

A website has been launched by Avacta Life Sciences in order to showcase its new affimer technology. Read more

Technology

Catalent has signed an exclusive licencing agreement to access Excelimmune's antibody combination therapy technology platform, which has the potential to pave the way for more consistent, cost-effective production of antibody combinations. Read more

News

The search engine is a powerful clone, antibody and protein products search and buying tool, which gives researchers easy access to millions of products Read more

News

The agreement will give customers faster, easier access to Abcam’s high-quality antibodies. Read more

The range is for use in key imaging applications including immunofluorescence, flow cytometry, and fluorescent western blotting. Read more

Technology